Aquaporin 4 Monoclonal Antibody(4H1)

This gene encodes a member of the aquaporin family of intrinsic membrane proteins that function as water-selective channels in the plasma membranes of many cells. This protein is the predominant aquaporin found in brain and has an important role in brain water homeostasis. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. A recent study provided evidence for translational readthrough in this gene and expression of an additional C-terminally extended isoform via the use of an alternative in-frame translation termination codon.

Introducing the AQUAPORIN 4 Monoclonal Antibody (4H1), a cutting-edge pharmaceutical product designed to target and neutralize the Aquaporin 4 protein. This monoclonal antibody is meticulously engineered to exhibit exceptional specificity and affinity towards Aquaporin 4, making it an invaluable tool in various research and therapeutic applications.

The AQUAPORIN 4 Monoclonal Antibody (4H1) is developed using state-of-the-art technology, ensuring its high purity and consistency. Its exceptional binding affinity enables precise and efficient recognition of Aquaporin 4, facilitating accurate detection and analysis in experimental settings. This antibody's superior specificity guarantees minimal cross-reactivity, ensuring reliable and reproducible results.

This groundbreaking product holds immense potential in the field of neuroscience, particularly in the study of neurological disorders such as neuromyelitis optica (NMO) and multiple sclerosis (MS). By selectively targeting Aquaporin 4, the AQUAPORIN 4 Monoclonal Antibody (4H1) aids in elucidating the underlying mechanisms of these diseases, paving the way for novel therapeutic interventions.

Furthermore, this monoclonal antibody exhibits remarkable stability and longevity, ensuring its suitability for long-term storage and repeated use. Its compatibility with various experimental techniques, including immunohistochemistry, immunofluorescence, and Western blotting, further enhances its versatility and applicability in diverse research settings.

The AQUAPORIN 4 Monoclonal Antibody (4H1) is meticulously manufactured under stringent quality control measures, adhering to the highest industry standards. Each batch undergoes rigorous testing to guarantee its efficacy, reliability, and safety. This commitment to quality ensures that researchers and clinicians can confidently rely on this product for their scientific investigations and therapeutic endeavors.

In summary, the AQUAPORIN 4 Monoclonal Antibody (4H1) represents a breakthrough in the field of molecular biology and neuroscience. Its exceptional specificity, affinity, and stability make it an indispensable tool for researchers and clinicians alike, enabling them to unravel the complexities of Aquaporin 4-related disorders and develop innovative therapeutic strategies.